In a move that pushes Allegheny County Jail closer to the forefront of harm reduction efforts within the state’s correctional facilities, Acting Warden Shane T. Dady announced on Friday an expansion of its medication-assisted treatment program, or medication to treat opioid use disorder (MOUD). Following eight years of offering various types of MOUD, the jail will now prescribe buprenorphine, a key medication in the harm reduction arsenal.

Previously, only those with an existing buprenorphine prescription prior to incarceration could receive the drug. The expansion already includes 12 people, per a Dec. 29 news release, with the buprenorphine prescriptions handled by health care professionals from Allegheny Health Network.

Buprenorphine helps people with opioid use disorder manage cravings and withdrawal symptoms because it partially activates the brain’s opioid receptors, softening the roller coaster of physiological addiction. Allegheny County Jail also offers methadone continuation services through third-party company Tadiso, as well as oral naltrexone and Vivitrol, and naltrexone injection, upon release.

The announcement is part of a statewide effort to expand medication options for opioid use disorder. In June, Reps. Maureen Madden, D-Monroe, and Michael Schlossberg, D-Lehigh, introduced House Bill 1515, which would expand MOUD across all Pennsylvania jails by allowing the facilities to pull from Act 80 grant funding for counties. The bill was referred to the Senate Judiciary in July and remains there.

Advertise with us

Jody Glance, an addiction medicine specialist at UPMC, said in an earlier interview about MOUD that she was excited to see attention for these medications move to the forefront.

“[MOUD] helps bridge the gap between when they leave prison and enter treatment,” she said. “It helps increase the chances that they stay alive so that they can make it to their treatment.”

Alice Bell, overdose prevention project coordinator at Prevention Point Pittsburgh, said the buprenorphine expansion was good news.

“This is something we have been pushing for for a long time,” she said.

Data from Allegheny County Jail oversight board meetings since June show an average of 155 inmates on two available forms of buprenorphine, representing 9.4% of the total inmates at ACJ, per Jan. 3. The number of those on Suboxone (a brand-name buprenorphine) has increased slightly since June, with 120 inmates on the medication during the month of June and 146 on it in November, the latest data available.

Advertise with us

An average of 43 inmates have been on methadone continuation services each month since June, and an average of 32 are receiving oral naltrexone.

“We know that additional individuals can benefit from this treatment,” said Mr. Dady in a Friday news release. “Many of those committed to our facility have a history of substance use but might not have previously benefited from medication-assisted treatment. This is another way in which we’re able to help assist those entrusted to our care and custody in their recovery.”

The jail began offering buprenorphine to pregnant people in 2016 and expanded services to non-pregnant people in 2019. The jail also expanded its methadone continuation services in 2022 from pregnant people to people with a prescription. It plans to be able to induct methadone, or start people on a prescription, by October, according to the release.

Per a 2022 report by the Pennsylvania Institutional Law Project, just over half of Pennsylvania jails offer “only the least effective form of MOUD”: naltrexone, which blocks opioid receptors but does not address withdrawal symptoms. Four jails in the commonwealth — out of 62 total — administered MOUD. In Western Pennsylvania, Beaver, Butler and Westmoreland offer naltrexone only. Washington County offers medication for opioid use disorder to pregnant people, according to the report, and Armstrong offers continuation services.

The Department of Justice in November alleged that ACJ violated the Americans with Disabilities Act by denying methadone access to an incarcerated individual despite them having a prescription. Former employees of ACJ, as well as third-party audits, have discussed a past of short staffing of health positions at the jail, frequent missed prescriptions, low morale among corrections officers and issues with the detoxification process.

Advertise with us

Under the settlement agreement, with oversight set to last three years, ACJ must pay the individual $10,000 and implement policies and personnel — with training approved by DOJ officials — to ensure inmates have access to medication for opioid use disorder.

As part of the expanded services, six out of 10 substance use recovery nurses have been hired and begun screening patients in the jail. The news release announced the hiring of two additional nurses who are receiving training.

ACJ is also partnering with the state Department of Health and Human Services and local peer support group Unity Recovery to improve continuation of medication upon release, protecting against fatal overdose.

Robert Ashford, executive director of Unity Recovery, confirmed the team is providing full-scale reentry services under the new partnership as a kind of pilot program. If inmates test positive for opioids upon booking, Unity is given a referral. Mr. Ashford said peer support specialists have been going into the jail and working directly with inmates every day since the pilot’s launch in December, and that they have already received 15 referrals.

“I am excited to be working with the medical team and the county,” he said. “The partnership is really doing some innovative stuff, and the level of peer integration is a first for the jail.”

Advertise with us

He applauded the county and the jail for the expansion of MOUD with buprenorphine induction, and said it was a big step forward.

“Is it perfect? No,” he said. “The reality is, all these medications need to be available equitably, and methadone induction isn’t there yet. There’s a lot of work to be done, but I think this team deserves credit.”

Hanna Webster: hwebster@post-gazette.com